These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9081676)

  • 1. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
    Wild SH; Fortmann SP; Marcovina SM
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty.
    Sirikci O; Aytekin V; Demiroglu IC; Demiroglu C; Marcovina SM
    Int J Clin Lab Res; 2000; 30(2):93-9. PubMed ID: 11043503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study.
    Rifai N; Ma J; Sacks FM; Ridker PM; Hernandez WJ; Stampfer MJ; Marcovina SM
    Clin Chem; 2004 Aug; 50(8):1364-71. PubMed ID: 15155542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
    Saku K; Zhang B; Liu R; Shirai K; Arakawa K
    Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.
    Martín S; Pedro-Botet J; Joven J; Simó JM; Ladona MG; Pavesi M; Rubiés-Prat J
    J Lab Clin Med; 2002 Mar; 139(3):181-7. PubMed ID: 11944029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia.
    Bowden JF; Pritchard PH; Hill JS; Frohlich JJ
    Arterioscler Thromb; 1994 Oct; 14(10):1561-8. PubMed ID: 7918305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
    Farrer M; Game FL; Albers CJ; Neil HA; Winocour PH; Laker MF; Adams PC; Alberti KG
    Arterioscler Thromb; 1994 Aug; 14(8):1272-83. PubMed ID: 8049188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
    Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O
    Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
    Paultre F; Pearson TA; Weil HF; Tuck CH; Myerson M; Rubin J; Francis CK; Marx HF; Philbin EF; Reed RG; Berglund L
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2619-24. PubMed ID: 11116062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
    Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS
    Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
    Brazier L; Tiret L; Luc G; Arveiler D; Ruidavets JB; Evans A; Chapman J; Cambien F; Thillet J
    Atherosclerosis; 1999 Jun; 144(2):323-33. PubMed ID: 10407493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study.
    Klausen IC; Sjøl A; Hansen PS; Gerdes LU; Møller L; Lemming L; Schroll M; Faergeman O
    Atherosclerosis; 1997 Jul; 132(1):77-84. PubMed ID: 9247362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults.
    Beheshtian A; Shitole SG; Segal AZ; Leifer D; Tracy RP; Rader DJ; Devereux RB; Kizer JR
    Atherosclerosis; 2016 Oct; 253():47-53. PubMed ID: 27575936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
    Emanuele E; Peros E; Minoretti P; D'Angelo A; Piccinni MN; Montagna L; Geroldi D
    Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.
    Brown SA; Morrisett JD; Boerwinkle E; Hutchinson R; Patsch W
    Arterioscler Thromb; 1993 Nov; 13(11):1558-66. PubMed ID: 8218095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes.
    Ruiz J; Thillet J; Huby T; James RW; Erlich D; Flandre P; Froguel P; Chapman J; Passa P
    Diabetologia; 1994 Jun; 37(6):585-91. PubMed ID: 7926343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population.
    Akanji AO
    Ann Clin Biochem; 2000 May; 37 ( Pt 3)():360-6. PubMed ID: 10817252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population.
    Kark JD; Sandholzer C; Friedlander Y; Utermann G
    Atherosclerosis; 1993 Jan; 98(2):139-51. PubMed ID: 8457257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.